News | Artificial Intelligence | November 29, 2019

Oxipit to Showcase AI X-ray Longitudinal Comparison at RSNA

Dynamics enables a radiologist to compare X-rays and provide automatically generated reports specifically addressing the changes in images over the course of patient treatment

#RSNA19 Dynamics enables a radiologist to compare X-rays and provide automatically generated reports specifically addressing the changes in images over the course of patient treatment. Initially Dynamics feature will support longitudinal comparison for pneumothorax, consolidation, mass, nodule, pleural effusion, pulmonary edema and lung congestion radiological findings where progress reports are of greatest importance

November 29, 2019 — At RSNA19 Oxipit will offer a first public preview of Dynamics feature for its award winning ChestEye CAD suite. Dynamics enables a radiologist to compare X-rays and provide automatically generated reports specifically addressing the changes in images over the course of patient treatment. Initially Dynamics feature will support longitudinal comparison for pneumothorax, consolidation, mass, nodule, pleural effusion, pulmonary edema and lung congestion radiological findings where progress reports are of greatest importance. 

“In radiology a lot of X-ray reporting specifically deals with comparison of how a condition progresses over time. Operating ‘under-the-hood’, ChestEye automatically compares the latest radiograph with a previous chest X-ray of the same patient and produces a concise report, which includes a description of the observed changes. This feature enables further gains in radiologist productivity and improves the performance of other ChestEye suite components as well," noted CEO of Oxipit Gediminas Peksys.

For example, ChestEye may detect lung nodules in both the previous and the current image. With Dynamics, ChestEye compares the size of the nodules and describes the progress of the condition in an automatically generated report. In the words of Mr Peksys, this allows for more actionable treatment decisions and brings ChestEye reporting closer towards reports written by a radiologist.

The feature also improves the performance of ChestEye Queue — a triage solution for patient management - as it takes into account the progress of patient condition.

“Dynamics further builds upon the vanguard capabilities of Oxipit ChestEye deep learning models, which enables us to develop new solutions for a more efficient radiology workflow,” noted Peksys.

At the RSNA conference Oxipit will also present ChestEye Quality and ChestEye Negative solutions.

ChestEye Quality is an automated clinical audit service for retrospective X-ray report analysis. Working in the background, the product analyses chest X-ray images as well as accompanying reports. ChestEye Quality then automatically highlights cases with the highest likelihood of important discrepancies.

“Current quality assurance procedures only select a small random sample of reports for secondary specialist analysis. ChestEye Quality enables to double-check all retrospective patient cases. Contrary to a periodic clinical audit, The ChestEye Quality solution operates in real-time, enabling to identify discrepancies that may affect patient treatment,” said Peksys.

ChestEye Negative produces preliminary reports for chest X-ray images with no abnormality. This enables radiologists to focus on the images with pathology. The product significantly assists the radiologist, especially in clinical environments with a low fraction of abnormal studies, such as large scale health screening projects and out-patient clinics.

For more information: www.oxipit.ai

Related content:

Study: AI Found to Reduce Bias in Radiology Reports

Related Content

New Medical Imaging and Data Resource Center will aid AI development and medical advancement to battle COVID-19

Getty Images

News | Coronavirus (COVID-19) | August 05, 2020
August 5, 2020 — The nation’s largest medical imaging associations are working together to develop the new Medical Im
Mobile CT scanner reimagines head imaging of critically ill patients by enabling patients and staff to remain in ICU
News | Computed Tomography (CT) | August 05, 2020
August 5, 2020 — The Food and Drug Administration (FDA) has cleared the...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

News | Coronavirus (COVID-19) | July 30, 2020
July 30, 2020 — A World Health Organization (WHO) rapid advice gui
 The Radiological Society of North America (RSNA) has been awarded a $750,000 grant by the Department of Energy’s National Nuclear Security Administration (NNSA) to develop a Global Learning Center (GLC) in Sub-Saharan Africa. The grant will help address the growing need in Sub-Saharan Africa for training in radiology.
News | Radiology Education | July 28, 2020
July 28, 2020 — The Radiological Society of North America (RSNA)
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510